NIFEdipine
| Form | Strength |
|---|---|
| CAPSULE, ORAL | 10 mg |
| TABLET, EXTENDED RELEASE, ORAL | 30 mg |
| 2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults. | |
|---|---|
| Medication: | NIFEdipine (Adalat, Procardia) |
| Criteria 1: Potentially inappropriate medication use in older adults. (Table 2) | |
| Comments | immediate release |
| Drug(s) | NIFEdipine |
| Rationale | Potential for hypotension; risk of precipitating myocardial ischemia. |
| Recommendation | Avoid |
| Quality of evidence: High, Strength of Recommendation: Strong | |